fanta.bio Sample: CNhs10842
22257 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 980 / 8712 (11.2%) | 230 / 87120 (0.3%) | −324.0 | −324.0 | 42.61 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1388 / 8712 (15.9%) | 395 / 87120 (0.5%) | −324.0 | −324.0 | 35.14 |
| HIF1A SRX11007095 | HK-2 Kidney | 1706 / 8712 (19.6%) | 538 / 87120 (0.6%) | −324.0 | −324.0 | 31.71 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1380 / 8712 (15.8%) | 465 / 87120 (0.5%) | −324.0 | −324.0 | 29.68 |
| SCML2 SRX644728 | 293 Kidney | 1137 / 8712 (13.1%) | 416 / 87120 (0.5%) | −324.0 | −324.0 | 27.33 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1856 / 8712 (21.3%) | 680 / 87120 (0.8%) | −324.0 | −324.0 | 27.29 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1778 / 8712 (20.4%) | 680 / 87120 (0.8%) | −324.0 | −324.0 | 26.15 |
| MYH11 SRX265221 | ME-1 Blood | 706 / 8712 (8.1%) | 322 / 87120 (0.4%) | −324.0 | −324.0 | 21.93 |
| FOXP1 SRX736067 | LNCAP Prostate | 1451 / 8712 (16.7%) | 682 / 87120 (0.8%) | −324.0 | −324.0 | 21.28 |
| MED1 SRX9419945 | BT-474 Breast | 2324 / 8712 (26.7%) | 1717 / 87120 (2.0%) | −324.0 | −324.0 | 13.54 |
| MED1 SRX9419944 | BT-474 Breast | 2272 / 8712 (26.1%) | 1703 / 87120 (2.0%) | −324.0 | −324.0 | 13.34 |
| BRD4 SRX9419935 | BT-474 Breast | 2286 / 8712 (26.2%) | 1723 / 87120 (2.0%) | −324.0 | −324.0 | 13.27 |
| BRD4 SRX9419937 | BT-474 Breast | 2271 / 8712 (26.1%) | 1726 / 87120 (2.0%) | −324.0 | −324.0 | 13.16 |
| BRD4 SRX9419936 | BT-474 Breast | 2347 / 8712 (26.9%) | 1785 / 87120 (2.0%) | −324.0 | −324.0 | 13.15 |
| MED1 SRX9419947 | BT-474 Breast | 2286 / 8712 (26.2%) | 1761 / 87120 (2.0%) | −324.0 | −324.0 | 12.98 |
| MED1 SRX9419946 | BT-474 Breast | 2339 / 8712 (26.8%) | 1810 / 87120 (2.1%) | −324.0 | −324.0 | 12.92 |
| BRD4 SRX9419938 | BT-474 Breast | 2291 / 8712 (26.3%) | 1793 / 87120 (2.1%) | −324.0 | −324.0 | 12.78 |
| EZH2 SRX2146136 | LNCAP Prostate | 5182 / 8712 (59.5%) | 4568 / 87120 (5.2%) | −324.0 | −324.0 | 11.34 |
| BRD4 SRX736201 | 90-8TL Neural | 4040 / 8712 (46.4%) | 3741 / 87120 (4.3%) | −324.0 | −324.0 | 10.80 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1216 / 8712 (14.0%) | 1524 / 87120 (1.7%) | −324.0 | −324.0 | 7.98 |
| TP53 SRX19538279 | Osteoblasts Bone | 405 / 8712 (4.6%) | 135 / 87120 (0.2%) | −300.4 | −297.2 | 30.00 |
| TP53 SRX19538274 | U2OS Bone | 343 / 8712 (3.9%) | 87 / 87120 (0.1%) | −270.6 | −267.4 | 39.43 |
| HIF1A SRX20663235 | HK-2 Kidney | 379 / 8712 (4.4%) | 146 / 87120 (0.2%) | −270.4 | −267.2 | 25.96 |
| TP53 SRX19538268 | U2OS Bone | 335 / 8712 (3.8%) | 88 / 87120 (0.1%) | −262.3 | −259.2 | 38.07 |
| TP53 SRX19538276 | U2OS Bone | 332 / 8712 (3.8%) | 87 / 87120 (0.1%) | −260.1 | −257.0 | 38.16 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 345 / 8712 (4.0%) | 121 / 87120 (0.1%) | −252.3 | −249.2 | 28.51 |
| TP53 SRX19538280 | Osteoblasts Bone | 330 / 8712 (3.8%) | 112 / 87120 (0.1%) | −243.3 | −240.2 | 29.46 |
| TP53 SRX19538281 | Osteoblasts Bone | 347 / 8712 (4.0%) | 150 / 87120 (0.2%) | −239.3 | −236.2 | 23.13 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 683 / 8712 (7.8%) | 1178 / 87120 (1.4%) | −237.9 | −234.8 | 5.80 |
| TP53 SRX19538275 | U2OS Bone | 305 / 8712 (3.5%) | 84 / 87120 (0.1%) | −236.3 | −233.2 | 36.31 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 503 / 8712 (5.8%) | 560 / 87120 (0.6%) | −233.9 | −230.8 | 8.98 |
| TP53 SRX19538269 | U2OS Bone | 371 / 8712 (4.3%) | 212 / 87120 (0.2%) | −233.4 | −230.4 | 17.50 |
| TP53 SRX19538267 | U2OS Bone | 299 / 8712 (3.4%) | 81 / 87120 (0.1%) | −232.5 | −229.4 | 36.91 |
| 5-mC SRX882970 | LNCAP Prostate | 1864 / 8712 (21.4%) | 7979 / 87120 (9.2%) | −228.3 | −225.3 | 2.34 |
| TP53 SRX19538273 | U2OS Bone | 294 / 8712 (3.4%) | 81 / 87120 (0.1%) | −227.7 | −224.7 | 36.30 |
| 5-mC SRX882968 | LNCAP Prostate | 1832 / 8712 (21.0%) | 7927 / 87120 (9.1%) | −219.2 | −216.3 | 2.31 |
| PBX4 SRX2731658 | PC-3 Prostate | 392 / 8712 (4.5%) | 13355 / 87120 (15.3%) | −211.6 | −208.7 | 0.29 |
| TP53 SRX19538270 | U2OS Bone | 346 / 8712 (4.0%) | 220 / 87120 (0.3%) | −209.0 | −206.1 | 15.73 |
| BRD4 SRX736204 | 90-8TL Neural | 713 / 8712 (8.2%) | 1530 / 87120 (1.8%) | −205.8 | −202.9 | 4.66 |
| 5-mC SRX882965 | LNCAP Prostate | 1522 / 8712 (17.5%) | 6240 / 87120 (7.2%) | −197.0 | −194.1 | 2.44 |
| AR SRX10820653 | LNCAP Prostate | 281 / 8712 (3.2%) | 121 / 87120 (0.1%) | −193.8 | −190.9 | 23.22 |
| TP53 SRX19538282 | Osteoblasts Bone | 295 / 8712 (3.4%) | 158 / 87120 (0.2%) | −189.7 | −186.8 | 18.67 |
| AGO2 SRX4708039 | Hep G2 Liver | 1142 / 8712 (13.1%) | 3970 / 87120 (4.6%) | −189.6 | −186.7 | 2.88 |
| TP53 SRX19538271 | U2OS Bone | 460 / 8712 (5.3%) | 642 / 87120 (0.7%) | −185.6 | −182.7 | 7.17 |
| FOS SRX150477 | MCF 10A Breast | 255 / 8712 (2.9%) | 10151 / 87120 (11.7%) | −181.1 | −178.2 | 0.25 |
| AR SRX10820651 | LNCAP Prostate | 284 / 8712 (3.3%) | 164 / 87120 (0.2%) | −177.8 | −174.9 | 17.32 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 367 / 8712 (4.2%) | 379 / 87120 (0.4%) | −177.3 | −174.5 | 9.68 |
| FOS SRX150478 | MCF 10A Breast | 286 / 8712 (3.3%) | 10378 / 87120 (11.9%) | −170.7 | −167.9 | 0.28 |
| YAP1 SRX757325 | H2052 Lung | 304 / 8712 (3.5%) | 10545 / 87120 (12.1%) | −166.2 | −163.4 | 0.29 |
| IRF3 SRX11453858 | Hep G2 Liver | 206 / 8712 (2.4%) | 57 / 87120 (0.1%) | −159.3 | −156.5 | 36.14 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 390 / 8712 (4.5%) | 540 / 87120 (0.6%) | −157.9 | −155.1 | 7.22 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 355 / 8712 (4.1%) | 430 / 87120 (0.5%) | −156.5 | −153.7 | 8.26 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 741 / 8712 (8.5%) | 2162 / 87120 (2.5%) | −153.2 | −150.4 | 3.43 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 851 / 8712 (9.8%) | 2800 / 87120 (3.2%) | −150.6 | −147.8 | 3.04 |
| YAP1 SRX757326 | H2052 Lung | 267 / 8712 (3.1%) | 9419 / 87120 (10.8%) | −149.7 | −146.9 | 0.28 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 200 / 8712 (2.3%) | 67 / 87120 (0.1%) | −147.8 | −145.0 | 29.85 |
| RUNX1 SRX2513054 | 293 Kidney | 1816 / 8712 (20.8%) | 9350 / 87120 (10.7%) | −147.0 | −144.3 | 1.94 |
| NFYB SRX16608147 | HeLa Uterus | 220 / 8712 (2.5%) | 107 / 87120 (0.1%) | −146.1 | −143.3 | 20.56 |
| FOS SRX4192880 | MCF 10A Breast | 205 / 8712 (2.4%) | 8230 / 87120 (9.4%) | −145.7 | −142.9 | 0.25 |
| STAT5B SRX831881 | CD8+ T cells Blood | 199 / 8712 (2.3%) | 72 / 87120 (0.1%) | −144.2 | −141.4 | 27.64 |
| TP53 SRX19538272 | U2OS Bone | 379 / 8712 (4.4%) | 578 / 87120 (0.7%) | −143.5 | −140.7 | 6.56 |
| CDK9 SRX7366783 | MCF-7 Breast | 194 / 8712 (2.2%) | 71 / 87120 (0.1%) | −140.1 | −137.4 | 27.32 |
| IRF3 SRX11453861 | Hep G2 Liver | 184 / 8712 (2.1%) | 61 / 87120 (0.1%) | −136.4 | −133.6 | 30.16 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 680 / 8712 (7.8%) | 2028 / 87120 (2.3%) | −136.3 | −133.6 | 3.35 |
| FOXA1 SRX4815198 | MCF-7 Breast | 471 / 8712 (5.4%) | 12076 / 87120 (13.9%) | −133.3 | −130.6 | 0.39 |
| Epitope tags SRX10549776 | K-562 Blood | 817 / 8712 (9.4%) | 2840 / 87120 (3.3%) | −133.0 | −130.3 | 2.88 |
| CDK9 SRX7366781 | MCF-7 Breast | 182 / 8712 (2.1%) | 67 / 87120 (0.1%) | −131.3 | −128.6 | 27.16 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 311 / 8712 (3.6%) | 9543 / 87120 (11.0%) | −130.6 | −127.9 | 0.33 |
| BMI1 SRX644729 | 293 Kidney | 184 / 8712 (2.1%) | 75 / 87120 (0.1%) | −129.0 | −126.3 | 24.53 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 400 / 8712 (4.6%) | 756 / 87120 (0.9%) | −128.0 | −125.3 | 5.29 |
| FOXA1 SRX176862 | MCF-7 Breast | 164 / 8712 (1.9%) | 6936 / 87120 (8.0%) | −126.9 | −124.3 | 0.24 |
| FOS SRX150517 | MCF 10A Breast | 239 / 8712 (2.7%) | 8168 / 87120 (9.4%) | −124.4 | −121.8 | 0.29 |
| FOS SRX150476 | MCF 10A Breast | 244 / 8712 (2.8%) | 8250 / 87120 (9.5%) | −124.3 | −121.6 | 0.30 |
| RELA SRX2207673 | HUVEC Cardiovascular | 566 / 8712 (6.5%) | 13110 / 87120 (15.0%) | −124.1 | −121.4 | 0.43 |
| FOXA1 SRX4815197 | MCF-7 Breast | 345 / 8712 (4.0%) | 9828 / 87120 (11.3%) | −123.0 | −120.4 | 0.35 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1158 / 8712 (13.3%) | 5212 / 87120 (6.0%) | −121.7 | −119.1 | 2.22 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 356 / 8712 (4.1%) | 9916 / 87120 (11.4%) | −120.7 | −118.1 | 0.36 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 391 / 8712 (4.5%) | 773 / 87120 (0.9%) | −120.3 | −117.7 | 5.06 |
| GATA3 SRX190194 | SK-N-SH Neural | 361 / 8712 (4.1%) | 9948 / 87120 (11.4%) | −119.4 | −116.8 | 0.36 |
| FOXA1 SRX176863 | MCF-7 Breast | 156 / 8712 (1.8%) | 6563 / 87120 (7.5%) | −119.4 | −116.8 | 0.24 |
| SS18 SRX3468047 | Fibroblasts Others | 379 / 8712 (4.4%) | 10188 / 87120 (11.7%) | −118.4 | −115.8 | 0.37 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 327 / 8712 (3.8%) | 548 / 87120 (0.6%) | −115.3 | −112.6 | 5.97 |
| ESR1 SRX371478 | MCF-7 Breast | 182 / 8712 (2.1%) | 6901 / 87120 (7.9%) | −115.1 | −112.5 | 0.26 |
| RELA SRX2207672 | HUVEC Cardiovascular | 636 / 8712 (7.3%) | 13701 / 87120 (15.7%) | −114.1 | −111.5 | 0.46 |
| FOXA1 SRX3931044 | MCF-7 Breast | 323 / 8712 (3.7%) | 9173 / 87120 (10.5%) | −113.8 | −111.2 | 0.35 |
| AGO2 SRX6783957 | Hep G2 Liver | 689 / 8712 (7.9%) | 2366 / 87120 (2.7%) | −113.6 | −111.0 | 2.91 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 395 / 8712 (4.5%) | 10246 / 87120 (11.8%) | −113.2 | −110.7 | 0.39 |
| FOXA1 SRX371481 | MCF-7 Breast | 148 / 8712 (1.7%) | 6221 / 87120 (7.1%) | −112.8 | −110.2 | 0.24 |
| AR SRX1067071 | LHSAR Prostate | 305 / 8712 (3.5%) | 8845 / 87120 (10.2%) | −112.5 | −109.9 | 0.34 |
| CIC SRX13262055 | Astrocytes Neural | 1619 / 8712 (18.6%) | 8823 / 87120 (10.1%) | −110.6 | −108.1 | 1.83 |
| AGO2 SRX6783958 | Hep G2 Liver | 673 / 8712 (7.7%) | 2315 / 87120 (2.7%) | −110.6 | −108.1 | 2.91 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 548 / 8712 (6.3%) | 12345 / 87120 (14.2%) | −110.5 | −107.9 | 0.44 |
| FOXA1 SRX371482 | MCF-7 Breast | 214 / 8712 (2.5%) | 7277 / 87120 (8.4%) | −109.5 | −106.9 | 0.29 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 376 / 8712 (4.3%) | 9824 / 87120 (11.3%) | −109.3 | −106.8 | 0.38 |
| GATA3 SRX190239 | MCF-7 Breast | 224 / 8712 (2.6%) | 7431 / 87120 (8.5%) | −109.1 | −106.6 | 0.30 |
| ESR1 SRX7624157 | MCF-7 Breast | 422 / 8712 (4.8%) | 10454 / 87120 (12.0%) | −108.0 | −105.5 | 0.40 |
| ESR1 SRX371469 | MCF-7 Breast | 153 / 8712 (1.8%) | 6163 / 87120 (7.1%) | −107.9 | −105.3 | 0.25 |
| FOXA1 SRX1161177 | MCF-7 Breast | 147 / 8712 (1.7%) | 6045 / 87120 (6.9%) | −107.5 | −105.0 | 0.24 |
| FOS SRX4192879 | MCF 10A Breast | 169 / 8712 (1.9%) | 6415 / 87120 (7.4%) | −106.7 | −104.2 | 0.26 |
| JUN SRX17561461 | LPS141 Adipocyte | 221 / 8712 (2.5%) | 7258 / 87120 (8.3%) | −105.2 | −102.7 | 0.30 |
| CEBPB SRX150632 | HeLa Uterus | 362 / 8712 (4.2%) | 9459 / 87120 (10.9%) | −105.0 | −102.5 | 0.38 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 561 / 8712 (6.4%) | 12306 / 87120 (14.1%) | −104.8 | −102.3 | 0.46 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 324 / 8712 (3.7%) | 605 / 87120 (0.7%) | −104.6 | −102.1 | 5.36 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 306 / 8712 (3.5%) | 533 / 87120 (0.6%) | −104.6 | −102.1 | 5.74 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 138 / 8712 (1.6%) | 5787 / 87120 (6.6%) | −104.4 | −101.9 | 0.24 |
| TCF12 SRX190356 | SK-N-SH Neural | 453 / 8712 (5.2%) | 10743 / 87120 (12.3%) | −103.7 | −101.2 | 0.42 |
| FOXA1 SRX371483 | MCF-7 Breast | 173 / 8712 (2.0%) | 6389 / 87120 (7.3%) | −103.7 | −101.2 | 0.27 |
| TLE3 SRX4815191 | MCF-7 Breast | 145 / 8712 (1.7%) | 5890 / 87120 (6.8%) | −103.6 | −101.2 | 0.25 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 270 / 8712 (3.1%) | 7994 / 87120 (9.2%) | −103.6 | −101.1 | 0.34 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 312 / 8712 (3.6%) | 8635 / 87120 (9.9%) | −103.2 | −100.7 | 0.36 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 353 / 8712 (4.1%) | 9251 / 87120 (10.6%) | −102.9 | −100.5 | 0.38 |
| JUNB SRX8488088 | SUM 229PE Breast | 323 / 8712 (3.7%) | 8731 / 87120 (10.0%) | −101.0 | −98.5 | 0.37 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 135 / 8712 (1.5%) | 5620 / 87120 (6.5%) | −100.6 | −98.2 | 0.24 |
| ESR1 SRX371471 | ZR-75-1 Breast | 168 / 8712 (1.9%) | 6210 / 87120 (7.1%) | −100.6 | −98.1 | 0.27 |
| FOXA1 SRX371480 | MCF-7 Breast | 95 / 8712 (1.1%) | 4849 / 87120 (5.6%) | −100.3 | −97.9 | 0.20 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 135 / 8712 (1.5%) | 45 / 87120 (0.1%) | −100.0 | −97.6 | 30.00 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 411 / 8712 (4.7%) | 9993 / 87120 (11.5%) | −99.8 | −97.3 | 0.41 |
| NR3C1 SRX2609664 | HASM2 Lung | 222 / 8712 (2.5%) | 7092 / 87120 (8.1%) | −99.8 | −97.3 | 0.31 |
| JUN SRX6582171 | GM07492 Others | 323 / 8712 (3.7%) | 8680 / 87120 (10.0%) | −99.6 | −97.2 | 0.37 |
| ESR1 SRX371470 | ZR-75-1 Breast | 141 / 8712 (1.6%) | 5695 / 87120 (6.5%) | −99.5 | −97.0 | 0.25 |
| FOXL2 SRX6957431 | KGN Gonad | 383 / 8712 (4.4%) | 9562 / 87120 (11.0%) | −99.2 | −96.7 | 0.40 |
| AR SRX1067070 | LHSAR Prostate | 419 / 8712 (4.8%) | 10086 / 87120 (11.6%) | −99.1 | −96.7 | 0.42 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 234 / 8712 (2.7%) | 7266 / 87120 (8.3%) | −99.0 | −96.6 | 0.32 |
| KAT6A SRX20971022 | Fibroblasts Others | 146 / 8712 (1.7%) | 67 / 87120 (0.1%) | −98.9 | −96.4 | 21.79 |
| ESR1 SRX371476 | MCF-7 Breast | 110 / 8712 (1.3%) | 5096 / 87120 (5.8%) | −98.8 | −96.4 | 0.22 |
| TRP47 SRX4548329 | THP-1 Blood | 1378 / 8712 (15.8%) | 7332 / 87120 (8.4%) | −98.8 | −96.3 | 1.88 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 191 / 8712 (2.2%) | 6538 / 87120 (7.5%) | −98.6 | −96.2 | 0.29 |
| GATA3 SRX176864 | MCF-7 Breast | 106 / 8712 (1.2%) | 5014 / 87120 (5.8%) | −98.5 | −96.1 | 0.21 |
| ESR1 SRX4367193 | MCF-7 Breast | 560 / 8712 (6.4%) | 12011 / 87120 (13.8%) | −97.7 | −95.3 | 0.47 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 388 / 8712 (4.5%) | 9572 / 87120 (11.0%) | −97.5 | −95.1 | 0.41 |
| FOXA1 SRX100454 | T-47D Breast | 205 / 8712 (2.4%) | 6727 / 87120 (7.7%) | −97.1 | −94.7 | 0.30 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 556 / 8712 (6.4%) | 11925 / 87120 (13.7%) | −96.9 | −94.5 | 0.47 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 206 / 8712 (2.4%) | 6721 / 87120 (7.7%) | −96.5 | −94.1 | 0.31 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 136 / 8712 (1.6%) | 54 / 87120 (0.1%) | −96.2 | −93.8 | 25.19 |
| FOXA1 SRX1161173 | MCF-7 Breast | 122 / 8712 (1.4%) | 5244 / 87120 (6.0%) | −96.1 | −93.7 | 0.23 |
| FOXA1 SRX1161176 | MCF-7 Breast | 154 / 8712 (1.8%) | 5820 / 87120 (6.7%) | −96.1 | −93.7 | 0.26 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 194 / 8712 (2.2%) | 6502 / 87120 (7.5%) | −95.9 | −93.5 | 0.30 |
| ESR1 SRX371479 | MCF-7 Breast | 151 / 8712 (1.7%) | 5760 / 87120 (6.6%) | −95.8 | −93.4 | 0.26 |
| JUNB SRX8488073 | SUM 229PE Breast | 325 / 8712 (3.7%) | 8569 / 87120 (9.8%) | −95.6 | −93.2 | 0.38 |
| GATA3 SRX5057632 | MCF-7 Breast | 94 / 8712 (1.1%) | 4686 / 87120 (5.4%) | −95.4 | −93.0 | 0.20 |
| ESR1 SRX7624156 | MCF-7 Breast | 282 / 8712 (3.2%) | 7888 / 87120 (9.1%) | −95.0 | −92.6 | 0.36 |
| Epitope tags SRX5877912 | U2OS Bone | 1026 / 8712 (11.8%) | 17911 / 87120 (20.6%) | −94.8 | −92.5 | 0.57 |
| JUN SRX6582172 | Fibroblasts Others | 221 / 8712 (2.5%) | 6907 / 87120 (7.9%) | −94.7 | −92.3 | 0.32 |
| AR SRX1067066 | LHSAR Prostate | 359 / 8712 (4.1%) | 9036 / 87120 (10.4%) | −94.5 | −92.2 | 0.40 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 370 / 8712 (4.2%) | 9198 / 87120 (10.6%) | −94.5 | −92.2 | 0.40 |
| SREBF2 SRX5359048 | HCC70 Breast | 904 / 8712 (10.4%) | 4047 / 87120 (4.6%) | −94.5 | −92.1 | 2.23 |
| FOXA1 SRX1161175 | MCF-7 Breast | 114 / 8712 (1.3%) | 5033 / 87120 (5.8%) | −94.1 | −91.8 | 0.23 |
| ESR1 SRX20282961 | MCF-7 Breast | 218 / 8712 (2.5%) | 6835 / 87120 (7.8%) | −94.0 | −91.6 | 0.32 |
| CDK9 SRX7366779 | MCF-7 Breast | 136 / 8712 (1.6%) | 59 / 87120 (0.1%) | −93.7 | −91.4 | 23.05 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 922 / 8712 (10.6%) | 4187 / 87120 (4.8%) | −93.6 | −91.3 | 2.20 |
| STAT3 SRX150536 | MCF 10A Breast | 178 / 8712 (2.0%) | 6159 / 87120 (7.1%) | −93.6 | −91.3 | 0.29 |
| STAT3 SRX150479 | MCF 10A Breast | 146 / 8712 (1.7%) | 5601 / 87120 (6.4%) | −93.5 | −91.1 | 0.26 |
| EP300 SRX2671813 | Fibroblasts Others | 130 / 8712 (1.5%) | 5302 / 87120 (6.1%) | −93.2 | −90.9 | 0.25 |
| JUN SRX4192884 | MCF 10A Breast | 130 / 8712 (1.5%) | 5300 / 87120 (6.1%) | −93.1 | −90.8 | 0.25 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 278 / 8712 (3.2%) | 7755 / 87120 (8.9%) | −92.9 | −90.6 | 0.36 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 141 / 8712 (1.6%) | 5490 / 87120 (6.3%) | −92.9 | −90.6 | 0.26 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 223 / 8712 (2.6%) | 6880 / 87120 (7.9%) | −92.8 | −90.5 | 0.32 |
| ESR1 SRX176861 | MCF-7 Breast | 290 / 8712 (3.3%) | 7920 / 87120 (9.1%) | −92.4 | −90.0 | 0.37 |
| ESR1 SRX371468 | MCF-7 Breast | 100 / 8712 (1.1%) | 4698 / 87120 (5.4%) | −91.8 | −89.5 | 0.21 |
| SSRP1 SRX3436567 | HT-1080 Bone | 234 / 8712 (2.7%) | 339 / 87120 (0.4%) | −91.7 | −89.4 | 6.90 |
| YAP1 SRX5718140 | 293 Kidney | 299 / 8712 (3.4%) | 8030 / 87120 (9.2%) | −91.6 | −89.3 | 0.37 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 301 / 8712 (3.5%) | 8061 / 87120 (9.3%) | −91.5 | −89.2 | 0.37 |
| STAT3 SRX150630 | MCF 10A Breast | 148 / 8712 (1.7%) | 5572 / 87120 (6.4%) | −91.5 | −89.2 | 0.27 |
| JUNB SRX10119386 | MCF 10A Breast | 146 / 8712 (1.7%) | 5529 / 87120 (6.3%) | −91.3 | −89.0 | 0.26 |
| NR3C1 SRX2609665 | HASM2 Lung | 181 / 8712 (2.1%) | 6134 / 87120 (7.0%) | −91.2 | −88.9 | 0.30 |
| ESR1 SRX194572 | MCF-7 Breast | 99 / 8712 (1.1%) | 4661 / 87120 (5.4%) | −91.1 | −88.8 | 0.21 |
| ESR1 SRX176860 | MCF-7 Breast | 290 / 8712 (3.3%) | 7866 / 87120 (9.0%) | −90.9 | −88.6 | 0.37 |
| AR SRX1067067 | LHSAR Prostate | 294 / 8712 (3.4%) | 7927 / 87120 (9.1%) | −90.8 | −88.5 | 0.37 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 128 / 8712 (1.5%) | 5181 / 87120 (5.9%) | −90.4 | −88.1 | 0.25 |
| JUNB SRX4192882 | MCF 10A Breast | 128 / 8712 (1.5%) | 5169 / 87120 (5.9%) | −90.1 | −87.8 | 0.25 |
| FOXA1 SRX1161174 | MCF-7 Breast | 172 / 8712 (2.0%) | 5931 / 87120 (6.8%) | −89.8 | −87.5 | 0.29 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 348 / 8712 (4.0%) | 8699 / 87120 (10.0%) | −89.7 | −87.4 | 0.40 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 120 / 8712 (1.4%) | 5013 / 87120 (5.8%) | −89.7 | −87.4 | 0.24 |
| FOXA1 SRX1787653 | MCF-7 Breast | 134 / 8712 (1.5%) | 5267 / 87120 (6.0%) | −89.7 | −87.4 | 0.25 |
| FOXA1 SRX100506 | Hep G2 Liver | 230 / 8712 (2.6%) | 6886 / 87120 (7.9%) | −89.7 | −87.4 | 0.33 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 517 / 8712 (5.9%) | 11095 / 87120 (12.7%) | −89.6 | −87.3 | 0.47 |
| AR SRX9109110 | MDA-MB-453 Breast | 333 / 8712 (3.8%) | 8467 / 87120 (9.7%) | −89.5 | −87.3 | 0.39 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 111 / 8712 (1.3%) | 4838 / 87120 (5.6%) | −89.5 | −87.2 | 0.23 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 227 / 8712 (2.6%) | 6817 / 87120 (7.8%) | −89.0 | −86.7 | 0.33 |
| ESR1 SRX1531791 | MCF-7 Breast | 171 / 8712 (2.0%) | 5889 / 87120 (6.8%) | −88.9 | −86.7 | 0.29 |
| PBX3 SRX190343 | SK-N-SH Neural | 377 / 8712 (4.3%) | 9072 / 87120 (10.4%) | −88.4 | −86.1 | 0.42 |
| ESR1 SRX371467 | MCF-7 Breast | 187 / 8712 (2.1%) | 6138 / 87120 (7.0%) | −88.3 | −86.1 | 0.30 |
| RELA SRX7055007 | HAEC Cardiovascular | 325 / 8712 (3.7%) | 8306 / 87120 (9.5%) | −88.3 | −86.1 | 0.39 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 218 / 8712 (2.5%) | 6640 / 87120 (7.6%) | −88.1 | −85.8 | 0.33 |
| FOXA1 SRX1787655 | MCF-7 Breast | 73 / 8712 (0.8%) | 4042 / 87120 (4.6%) | −87.7 | −85.4 | 0.18 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 859 / 8712 (9.9%) | 3886 / 87120 (4.5%) | −87.6 | −85.3 | 2.21 |
| CEBPB SRX2194250 | SUM 159PT Breast | 204 / 8712 (2.3%) | 6396 / 87120 (7.3%) | −87.6 | −85.3 | 0.32 |
| CDK9 SRX7366780 | MCF-7 Breast | 125 / 8712 (1.4%) | 52 / 87120 (0.1%) | −87.3 | −85.0 | 24.04 |
| ETS1 SRX3033231 | HEYA8 Gonad | 179 / 8712 (2.1%) | 182 / 87120 (0.2%) | −87.2 | −85.0 | 9.84 |
| VGLL1 SRX24602130 | BT-20 Breast | 181 / 8712 (2.1%) | 5995 / 87120 (6.9%) | −87.1 | −84.8 | 0.30 |
| SMARCA4 SRX5212362 | Mel270 Others | 312 / 8712 (3.6%) | 8052 / 87120 (9.2%) | −86.8 | −84.6 | 0.39 |
| FOXA2 SRX3230382 | Hep G2 Liver | 241 / 8712 (2.8%) | 6962 / 87120 (8.0%) | −86.7 | −84.5 | 0.35 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 261 / 8712 (3.0%) | 7270 / 87120 (8.3%) | −86.6 | −84.4 | 0.36 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 155 / 8712 (1.8%) | 5538 / 87120 (6.4%) | −86.6 | −84.4 | 0.28 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 269 / 8712 (3.1%) | 7389 / 87120 (8.5%) | −86.5 | −84.3 | 0.36 |
| SMARCA2 SRX8119677 | MeT-5A Others | 294 / 8712 (3.4%) | 7772 / 87120 (8.9%) | −86.5 | −84.3 | 0.38 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 228 / 8712 (2.6%) | 6745 / 87120 (7.7%) | −86.5 | −84.3 | 0.34 |
| Epitope tags SRX5877914 | U2OS Bone | 1043 / 8712 (12.0%) | 17724 / 87120 (20.3%) | −86.5 | −84.2 | 0.59 |
| SMARCA4 SRX5212366 | Mel270 Others | 242 / 8712 (2.8%) | 6945 / 87120 (8.0%) | −85.9 | −83.7 | 0.35 |
| FOXA2 SRX100448 | Hep G2 Liver | 192 / 8712 (2.2%) | 6139 / 87120 (7.0%) | −85.8 | −83.6 | 0.31 |
| JUNB SRX8488074 | SUM 229PE Breast | 241 / 8712 (2.8%) | 6927 / 87120 (8.0%) | −85.8 | −83.6 | 0.35 |
| FOXA1 SRX3923514 | MCF-7 Breast | 176 / 8712 (2.0%) | 5871 / 87120 (6.7%) | −85.8 | −83.5 | 0.30 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 133 / 8712 (1.5%) | 5122 / 87120 (5.9%) | −85.6 | −83.4 | 0.26 |
| ESR1 SRX20282939 | MCF-7 Breast | 213 / 8712 (2.4%) | 6470 / 87120 (7.4%) | −85.5 | −83.3 | 0.33 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 223 / 8712 (2.6%) | 6628 / 87120 (7.6%) | −85.4 | −83.2 | 0.34 |
| ARID1A SRX5089376 | MCF-7 Breast | 151 / 8712 (1.7%) | 5424 / 87120 (6.2%) | −85.2 | −83.0 | 0.28 |
| NR3C1 SRX2609666 | HASM2 Lung | 166 / 8712 (1.9%) | 5675 / 87120 (6.5%) | −84.9 | −82.7 | 0.29 |
| RAC1 SRX10365541 | MCF-7 Breast | 88 / 8712 (1.0%) | 4261 / 87120 (4.9%) | −84.8 | −82.6 | 0.21 |
| NR3C1 SRX2609662 | HASM2 Lung | 213 / 8712 (2.4%) | 6442 / 87120 (7.4%) | −84.7 | −82.5 | 0.33 |
| YAP1 SRX10119364 | MCF 10A Breast | 143 / 8712 (1.6%) | 5268 / 87120 (6.0%) | −84.6 | −82.4 | 0.27 |
| FOXA1 SRX1787652 | MCF-7 Breast | 100 / 8712 (1.1%) | 4483 / 87120 (5.1%) | −84.4 | −82.2 | 0.22 |
| MAU2 SRX15710550 | Fibroblasts Others | 305 / 8712 (3.5%) | 7857 / 87120 (9.0%) | −84.3 | −82.1 | 0.39 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 542 / 8712 (6.2%) | 11222 / 87120 (12.9%) | −84.3 | −82.1 | 0.48 |
| ESR1 SRX194569 | MCF-7 Breast | 193 / 8712 (2.2%) | 6104 / 87120 (7.0%) | −84.2 | −82.1 | 0.32 |
| NR3C1 SRX2609659 | HASM2 Lung | 209 / 8712 (2.4%) | 6355 / 87120 (7.3%) | −84.0 | −81.8 | 0.33 |
| EP300 SRX2194266 | SUM 159PT Breast | 313 / 8712 (3.6%) | 7957 / 87120 (9.1%) | −83.8 | −81.6 | 0.39 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 698 / 8712 (8.0%) | 2897 / 87120 (3.3%) | −83.7 | −81.6 | 2.41 |
| ESR1 SRX371474 | BT-474 Breast | 72 / 8712 (0.8%) | 3897 / 87120 (4.5%) | −83.2 | −81.1 | 0.18 |
| CEBPA SRX4705113 | MOLM-13 Blood | 431 / 8712 (4.9%) | 9639 / 87120 (11.1%) | −83.1 | −80.9 | 0.45 |
| ESR1 SRX371477 | MCF-7 Breast | 81 / 8712 (0.9%) | 4075 / 87120 (4.7%) | −83.1 | −80.9 | 0.20 |
| FOXA1 SRX3931043 | MCF-7 Breast | 182 / 8712 (2.1%) | 5876 / 87120 (6.7%) | −82.9 | −80.7 | 0.31 |
| BMI1 SRX7196721 | SF8628 Neural | 882 / 8712 (10.1%) | 4148 / 87120 (4.8%) | −82.8 | −80.6 | 2.13 |
| WWTR1 SRX10119367 | MCF 10A Breast | 211 / 8712 (2.4%) | 6344 / 87120 (7.3%) | −82.8 | −80.6 | 0.33 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 112 / 8712 (1.3%) | 38 / 87120 (0.0%) | −82.7 | −80.5 | 29.47 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 340 / 8712 (3.9%) | 8318 / 87120 (9.5%) | −82.7 | −80.5 | 0.41 |
| EP300 SRX2194265 | SUM 159PT Breast | 284 / 8712 (3.3%) | 7477 / 87120 (8.6%) | −82.6 | −80.4 | 0.38 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 198 / 8712 (2.3%) | 6122 / 87120 (7.0%) | −82.3 | −80.2 | 0.32 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 280 / 8712 (3.2%) | 7407 / 87120 (8.5%) | −82.2 | −80.1 | 0.38 |
| NCOA1 SRX036638 | U2OS Bone | 112 / 8712 (1.3%) | 39 / 87120 (0.0%) | −82.2 | −80.0 | 28.72 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 153 / 8712 (1.8%) | 5362 / 87120 (6.2%) | −82.0 | −79.9 | 0.29 |
| FOXA1 SRX190181 | A549 Lung | 121 / 8712 (1.4%) | 4795 / 87120 (5.5%) | −82.0 | −79.8 | 0.25 |
| ESR1 SRX10365536 | MCF-7 Breast | 89 / 8712 (1.0%) | 4191 / 87120 (4.8%) | −81.8 | −79.6 | 0.21 |
| MITF SRX1555436 | 501A Epidermis | 1011 / 8712 (11.6%) | 5085 / 87120 (5.8%) | −81.6 | −79.5 | 1.99 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 232 / 8712 (2.7%) | 6637 / 87120 (7.6%) | −81.6 | −79.4 | 0.35 |
| EP300 SRX150579 | HeLa Uterus | 116 / 8712 (1.3%) | 4691 / 87120 (5.4%) | −81.6 | −79.4 | 0.25 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 187 / 8712 (2.1%) | 5914 / 87120 (6.8%) | −81.6 | −79.4 | 0.32 |
| AR SRX9469988 | LAPC-4 Prostate | 243 / 8712 (2.8%) | 6806 / 87120 (7.8%) | −81.4 | −79.3 | 0.36 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 988 / 8712 (11.3%) | 4925 / 87120 (5.7%) | −81.4 | −79.3 | 2.01 |
| MethylCap SRX014767 | NB-4 Blood | 897 / 8712 (10.3%) | 4283 / 87120 (4.9%) | −81.3 | −79.1 | 2.09 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 179 / 8712 (2.1%) | 5774 / 87120 (6.6%) | −81.3 | −79.1 | 0.31 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 332 / 8712 (3.8%) | 8145 / 87120 (9.3%) | −81.2 | −79.1 | 0.41 |
| MECOM SRX23677885 | HNT-34 Blood | 904 / 8712 (10.4%) | 4335 / 87120 (5.0%) | −81.2 | −79.1 | 2.09 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 933 / 8712 (10.7%) | 4539 / 87120 (5.2%) | −81.2 | −79.0 | 2.06 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 470 / 8712 (5.4%) | 1557 / 87120 (1.8%) | −81.0 | −78.9 | 3.02 |
| ARID5B SRX3230377 | Hep G2 Liver | 478 / 8712 (5.5%) | 10190 / 87120 (11.7%) | −80.6 | −78.4 | 0.47 |
| RAC1 SRX10365543 | MCF-7 Breast | 93 / 8712 (1.1%) | 4229 / 87120 (4.9%) | −80.5 | −78.4 | 0.22 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 149 / 8712 (1.7%) | 5238 / 87120 (6.0%) | −80.5 | −78.3 | 0.28 |
| AR SRX9109113 | MDA-MB-453 Breast | 360 / 8712 (4.1%) | 8524 / 87120 (9.8%) | −80.4 | −78.3 | 0.42 |
| FOSL2 SRX190296 | SK-N-SH Neural | 253 / 8712 (2.9%) | 6925 / 87120 (7.9%) | −80.4 | −78.3 | 0.37 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 372 / 8712 (4.3%) | 8694 / 87120 (10.0%) | −80.4 | −78.3 | 0.43 |
| FOXA1 SRX11222441 | MCF-7 Breast | 136 / 8712 (1.6%) | 5007 / 87120 (5.7%) | −80.3 | −78.2 | 0.27 |
| ESR1 SRX20282960 | MCF-7 Breast | 223 / 8712 (2.6%) | 6436 / 87120 (7.4%) | −79.8 | −77.7 | 0.35 |
| FOXA1 SRX11222437 | MCF-7 Breast | 130 / 8712 (1.5%) | 4886 / 87120 (5.6%) | −79.7 | −77.6 | 0.27 |
| ARID1A SRX5089379 | MCF-7 Breast | 185 / 8712 (2.1%) | 5819 / 87120 (6.7%) | −79.6 | −77.5 | 0.32 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 428 / 8712 (4.9%) | 1342 / 87120 (1.5%) | −79.6 | −77.4 | 3.19 |
| EP300 SRX100540 | SK-N-SH Neural | 277 / 8712 (3.2%) | 7258 / 87120 (8.3%) | −79.5 | −77.4 | 0.38 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 197 / 8712 (2.3%) | 6006 / 87120 (6.9%) | −79.5 | −77.3 | 0.33 |
| FOXA1 SRX100477 | Hep G2 Liver | 213 / 8712 (2.4%) | 6265 / 87120 (7.2%) | −79.4 | −77.3 | 0.34 |
| RELA SRX7054617 | HAEC Cardiovascular | 230 / 8712 (2.6%) | 6526 / 87120 (7.5%) | −79.3 | −77.2 | 0.35 |
| FOXA1 SRX028635 | MCF-7 Breast | 86 / 8712 (1.0%) | 4056 / 87120 (4.7%) | −79.2 | −77.1 | 0.21 |
| PRRX1 SRX15235713 | Hs 578T Breast | 228 / 8712 (2.6%) | 6491 / 87120 (7.5%) | −79.1 | −77.0 | 0.35 |
| MECOM SRX23677884 | HNT-34 Blood | 884 / 8712 (10.1%) | 4249 / 87120 (4.9%) | −79.0 | −76.9 | 2.08 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 164 / 8712 (1.9%) | 5442 / 87120 (6.2%) | −78.8 | −76.7 | 0.30 |
| CEBPB SRX150598 | IMR-90 Lung | 389 / 8712 (4.5%) | 8876 / 87120 (10.2%) | −78.8 | −76.7 | 0.44 |
| FOXA1 SRX1787651 | MCF-7 Breast | 100 / 8712 (1.1%) | 4313 / 87120 (5.0%) | −78.8 | −76.7 | 0.23 |
| FOXA1 SRX190282 | A549 Lung | 120 / 8712 (1.4%) | 4680 / 87120 (5.4%) | −78.8 | −76.7 | 0.26 |
| ESR1 SRX330069 | MCF-7 Breast | 112 / 8712 (1.3%) | 4526 / 87120 (5.2%) | −78.5 | −76.5 | 0.25 |
| GATA3 SRX5457550 | MCF-7 Breast | 211 / 8712 (2.4%) | 6199 / 87120 (7.1%) | −78.5 | −76.4 | 0.34 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 85 / 8712 (1.0%) | 4017 / 87120 (4.6%) | −78.5 | −76.4 | 0.21 |
| SMARCA4 SRX5212357 | Mel270 Others | 277 / 8712 (3.2%) | 7218 / 87120 (8.3%) | −78.4 | −76.3 | 0.38 |
| FOXL2 SRX6957477 | KGN Gonad | 188 / 8712 (2.2%) | 5822 / 87120 (6.7%) | −78.3 | −76.2 | 0.32 |
| CDK9 SRX7366782 | MCF-7 Breast | 111 / 8712 (1.3%) | 45 / 87120 (0.1%) | −78.1 | −76.1 | 24.67 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 169 / 8712 (1.9%) | 189 / 87120 (0.2%) | −78.1 | −76.0 | 8.94 |
| NKX2-1 SRX2164786 | A549 Lung | 310 / 8712 (3.6%) | 7700 / 87120 (8.8%) | −78.1 | −76.0 | 0.40 |
| WWTR1 SRX10119378 | MCF 10A Breast | 206 / 8712 (2.4%) | 6102 / 87120 (7.0%) | −78.0 | −75.9 | 0.34 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 379 / 8712 (4.4%) | 8691 / 87120 (10.0%) | −77.8 | −75.7 | 0.44 |
| ESR1 SRX10365535 | MCF-7 Breast | 154 / 8712 (1.8%) | 5236 / 87120 (6.0%) | −77.7 | −75.6 | 0.29 |
| ESR1 SRX371475 | BT-474 Breast | 89 / 8712 (1.0%) | 4070 / 87120 (4.7%) | −77.6 | −75.6 | 0.22 |
| FOXA1 SRX028634 | MCF-7 Breast | 85 / 8712 (1.0%) | 3992 / 87120 (4.6%) | −77.5 | −75.5 | 0.21 |
| FOXA1 SRX1447317 | MCF-7 Breast | 116 / 8712 (1.3%) | 4569 / 87120 (5.2%) | −77.5 | −75.5 | 0.25 |
| FOXA1 SRX3931055 | MCF-7 Breast | 158 / 8712 (1.8%) | 5289 / 87120 (6.1%) | −77.3 | −75.2 | 0.30 |
| CEBPB SRX2194249 | SUM 159PT Breast | 183 / 8712 (2.1%) | 5708 / 87120 (6.6%) | −77.3 | −75.2 | 0.32 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 170 / 8712 (2.0%) | 5492 / 87120 (6.3%) | −77.3 | −75.2 | 0.31 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 198 / 8712 (2.3%) | 5946 / 87120 (6.8%) | −77.2 | −75.2 | 0.33 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 181 / 8712 (2.1%) | 5670 / 87120 (6.5%) | −77.2 | −75.1 | 0.32 |
| JUND SRX150408 | HeLa Uterus | 165 / 8712 (1.9%) | 5402 / 87120 (6.2%) | −77.1 | −75.1 | 0.31 |
| FOXA1 SRX6878603 | LNCAP Prostate | 207 / 8712 (2.4%) | 6074 / 87120 (7.0%) | −76.8 | −74.7 | 0.34 |
| TLE3 SRX4815192 | MCF-7 Breast | 169 / 8712 (1.9%) | 5454 / 87120 (6.3%) | −76.7 | −74.7 | 0.31 |
| FOXA1 SRX3931054 | MCF-7 Breast | 176 / 8712 (2.0%) | 5571 / 87120 (6.4%) | −76.7 | −74.7 | 0.32 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 345 / 8712 (4.0%) | 8160 / 87120 (9.4%) | −76.7 | −74.6 | 0.42 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 180 / 8712 (2.1%) | 5632 / 87120 (6.5%) | −76.5 | −74.5 | 0.32 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 179 / 8712 (2.1%) | 5611 / 87120 (6.4%) | −76.4 | −74.3 | 0.32 |
| FOS SRX070879 | HUVEC Cardiovascular | 208 / 8712 (2.4%) | 6077 / 87120 (7.0%) | −76.4 | −74.3 | 0.34 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 174 / 8712 (2.0%) | 5522 / 87120 (6.3%) | −76.2 | −74.2 | 0.32 |
| CEBPA SRX2630241 | Hep G2 Liver | 235 / 8712 (2.7%) | 6497 / 87120 (7.5%) | −76.2 | −74.2 | 0.36 |
| JUNB SRX10119384 | MCF 10A Breast | 112 / 8712 (1.3%) | 4447 / 87120 (5.1%) | −76.0 | −74.0 | 0.25 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 177 / 8712 (2.0%) | 5562 / 87120 (6.4%) | −76.0 | −74.0 | 0.32 |
| CDK9 SRX7366784 | MCF-7 Breast | 108 / 8712 (1.2%) | 44 / 87120 (0.1%) | −75.9 | −73.9 | 24.55 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 170 / 8712 (2.0%) | 5445 / 87120 (6.3%) | −75.9 | −73.8 | 0.31 |
| JUN SRX6582163 | BJ-5ta Epidermis | 243 / 8712 (2.8%) | 6607 / 87120 (7.6%) | −75.8 | −73.8 | 0.37 |
| FOXA1 SRX11222442 | MCF-7 Breast | 124 / 8712 (1.4%) | 4654 / 87120 (5.3%) | −75.8 | −73.7 | 0.27 |
| FOXA1 SRX5323843 | MCF-7 Breast | 92 / 8712 (1.1%) | 4062 / 87120 (4.7%) | −75.6 | −73.5 | 0.23 |
| SMARCA4 SRX5212371 | Mel270 Others | 277 / 8712 (3.2%) | 7106 / 87120 (8.2%) | −75.3 | −73.3 | 0.39 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 281 / 8712 (3.2%) | 7165 / 87120 (8.2%) | −75.2 | −73.2 | 0.39 |
| FOXA1 SRX3923516 | MCF-7 Breast | 135 / 8712 (1.5%) | 4827 / 87120 (5.5%) | −75.1 | −73.1 | 0.28 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 208 / 8712 (2.4%) | 6030 / 87120 (6.9%) | −75.0 | −73.0 | 0.34 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 353 / 8712 (4.1%) | 8204 / 87120 (9.4%) | −74.9 | −72.9 | 0.43 |
| FOXA1 SRX5203303 | MCF-7 Breast | 58 / 8712 (0.7%) | 3371 / 87120 (3.9%) | −74.9 | −72.9 | 0.17 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 282 / 8712 (3.2%) | 7162 / 87120 (8.2%) | −74.9 | −72.8 | 0.39 |
| ESR1 SRX20282972 | MCF-7 Breast | 225 / 8712 (2.6%) | 6284 / 87120 (7.2%) | −74.6 | −72.5 | 0.36 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 200 / 8712 (2.3%) | 5884 / 87120 (6.8%) | −74.5 | −72.5 | 0.34 |
| RELA SRX5938177 | FaDu Others | 177 / 8712 (2.0%) | 5506 / 87120 (6.3%) | −74.4 | −72.3 | 0.32 |
| ESR1 SRX330070 | MCF-7 Breast | 97 / 8712 (1.1%) | 4115 / 87120 (4.7%) | −74.1 | −72.1 | 0.24 |
| SPI1 SRX2770855 | Macrophages Blood | 576 / 8712 (6.6%) | 11232 / 87120 (12.9%) | −74.0 | −72.0 | 0.51 |
| FOXA1 SRX3923517 | MCF-7 Breast | 136 / 8712 (1.6%) | 4804 / 87120 (5.5%) | −73.9 | −71.9 | 0.28 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 790 / 8712 (9.1%) | 3710 / 87120 (4.3%) | −73.9 | −71.9 | 2.13 |
| Epitope tags SRX5877913 | U2OS Bone | 1071 / 8712 (12.3%) | 17435 / 87120 (20.0%) | −73.8 | −71.8 | 0.61 |
| FOXA1 SRX9604647 | LNCAP Prostate | 300 / 8712 (3.4%) | 7394 / 87120 (8.5%) | −73.8 | −71.8 | 0.41 |
| PTEN SRX5416007 | SMMC-7721 Liver | 903 / 8712 (10.4%) | 4507 / 87120 (5.2%) | −73.8 | −71.7 | 2.00 |
| FOXA1 SRX11222438 | MCF-7 Breast | 99 / 8712 (1.1%) | 4135 / 87120 (4.7%) | −73.7 | −71.6 | 0.24 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 120 / 8712 (1.4%) | 74 / 87120 (0.1%) | −73.5 | −71.5 | 16.22 |
| PGR SRX1012655 | MCF-7 Breast | 123 / 8712 (1.4%) | 4566 / 87120 (5.2%) | −73.5 | −71.5 | 0.27 |
| YAP1 SRX1038945 | IMR-90 Lung | 146 / 8712 (1.7%) | 4959 / 87120 (5.7%) | −73.4 | −71.4 | 0.29 |
| TEAD1 SRX3401272 | MCF-7 Breast | 144 / 8712 (1.7%) | 4924 / 87120 (5.7%) | −73.4 | −71.3 | 0.29 |
| MECOM SRX23677896 | HNT-34 Blood | 1059 / 8712 (12.2%) | 5659 / 87120 (6.5%) | −73.2 | −71.2 | 1.87 |
| ESR1 SRX2943591 | MCF-7 Breast | 136 / 8712 (1.6%) | 4778 / 87120 (5.5%) | −73.1 | −71.1 | 0.28 |
| JUND SRX190357 | SK-N-SH Neural | 253 / 8712 (2.9%) | 6660 / 87120 (7.6%) | −73.1 | −71.0 | 0.38 |
| IKZF1 SRX2424551 | GM12878 Blood | 367 / 8712 (4.2%) | 8330 / 87120 (9.6%) | −73.0 | −71.0 | 0.44 |
| RELA SRX7054657 | HAEC Cardiovascular | 231 / 8712 (2.7%) | 6322 / 87120 (7.3%) | −73.0 | −71.0 | 0.37 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 182 / 8712 (2.1%) | 5538 / 87120 (6.4%) | −72.9 | −70.9 | 0.33 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 269 / 8712 (3.1%) | 6892 / 87120 (7.9%) | −72.7 | −70.7 | 0.39 |
| CEBPB SRX190345 | MCF-7 Breast | 146 / 8712 (1.7%) | 4936 / 87120 (5.7%) | −72.7 | −70.7 | 0.30 |
| GATA3 SRX6712581 | MCF-7 Breast | 156 / 8712 (1.8%) | 5102 / 87120 (5.9%) | −72.6 | −70.6 | 0.31 |
| MECOM SRX23677897 | HNT-34 Blood | 1024 / 8712 (11.8%) | 5422 / 87120 (6.2%) | −72.5 | −70.5 | 1.89 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 64 / 8712 (0.7%) | 3420 / 87120 (3.9%) | −72.4 | −70.4 | 0.19 |
| JUN SRX2355072 | HAEC Cardiovascular | 264 / 8712 (3.0%) | 6799 / 87120 (7.8%) | −72.3 | −70.3 | 0.39 |
| EP300 SRX1012648 | MCF-7 Breast | 90 / 8712 (1.0%) | 3925 / 87120 (4.5%) | −72.3 | −70.3 | 0.23 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 346 / 8712 (4.0%) | 7999 / 87120 (9.2%) | −72.2 | −70.2 | 0.43 |
| STAT3 SRX2020842 | HCC70 Breast | 358 / 8712 (4.1%) | 8168 / 87120 (9.4%) | −72.1 | −70.1 | 0.44 |
| EP300 SRX176885 | MCF-7 Breast | 98 / 8712 (1.1%) | 4069 / 87120 (4.7%) | −72.1 | −70.1 | 0.24 |
| FOXA1 SRX5203294 | MCF-7 Breast | 50 / 8712 (0.6%) | 3120 / 87120 (3.6%) | −72.0 | −70.0 | 0.16 |
| NR3C1 SRX2609661 | HASM2 Lung | 220 / 8712 (2.5%) | 6110 / 87120 (7.0%) | −71.9 | −69.9 | 0.36 |
| ESR1 SRX10365532 | MCF-7 Breast | 107 / 8712 (1.2%) | 4231 / 87120 (4.9%) | −71.9 | −69.9 | 0.25 |
| ESR1 SRX20282954 | MCF-7 Breast | 229 / 8712 (2.6%) | 6246 / 87120 (7.2%) | −71.8 | −69.8 | 0.37 |
| FOXA1 SRX6878604 | LNCAP Prostate | 153 / 8712 (1.8%) | 5023 / 87120 (5.8%) | −71.8 | −69.8 | 0.30 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 386 / 8712 (4.4%) | 8547 / 87120 (9.8%) | −71.7 | −69.7 | 0.45 |
| FOXA1 SRX219284 | LNCAP Prostate | 264 / 8712 (3.0%) | 6774 / 87120 (7.8%) | −71.6 | −69.7 | 0.39 |
| JUN SRX6582164 | BJ-5ta Epidermis | 252 / 8712 (2.9%) | 6593 / 87120 (7.6%) | −71.6 | −69.6 | 0.38 |
| BRPF3 SRX796085 | RKO Digestive tract | 508 / 8712 (5.8%) | 1917 / 87120 (2.2%) | −71.5 | −69.6 | 2.65 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 174 / 8712 (2.0%) | 5359 / 87120 (6.2%) | −71.4 | −69.4 | 0.32 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 270 / 8712 (3.1%) | 6853 / 87120 (7.9%) | −71.4 | −69.4 | 0.39 |
| VGLL1 SRX18013277 | FULVR Breast | 81 / 8712 (0.9%) | 3722 / 87120 (4.3%) | −71.1 | −69.1 | 0.22 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 893 / 8712 (10.3%) | 4510 / 87120 (5.2%) | −70.8 | −68.9 | 1.98 |
| ARID5B SRX10475138 | Hep G2 Liver | 343 / 8712 (3.9%) | 7902 / 87120 (9.1%) | −70.8 | −68.8 | 0.43 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 228 / 8712 (2.6%) | 6192 / 87120 (7.1%) | −70.8 | −68.8 | 0.37 |
| FOXA1 SRX3923519 | MCF-7 Breast | 120 / 8712 (1.4%) | 4422 / 87120 (5.1%) | −70.6 | −68.6 | 0.27 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 284 / 8712 (3.3%) | 7032 / 87120 (8.1%) | −70.6 | −68.6 | 0.40 |
| SSRP1 SRX3436566 | HT-1080 Bone | 164 / 8712 (1.9%) | 207 / 87120 (0.2%) | −70.5 | −68.6 | 7.92 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 945 / 8712 (10.8%) | 4894 / 87120 (5.6%) | −70.5 | −68.6 | 1.93 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 388 / 8712 (4.5%) | 1236 / 87120 (1.4%) | −70.5 | −68.6 | 3.14 |
| FOXA1 SRX9604645 | LNCAP Prostate | 281 / 8712 (3.2%) | 6988 / 87120 (8.0%) | −70.5 | −68.6 | 0.40 |
| FOXA1 SRX5323846 | MCF-7 Breast | 69 / 8712 (0.8%) | 3466 / 87120 (4.0%) | −70.5 | −68.5 | 0.20 |
| FOXA1 SRX3923511 | MCF-7 Breast | 69 / 8712 (0.8%) | 3469 / 87120 (4.0%) | −70.5 | −68.5 | 0.20 |
| FOXA1 SRX3923518 | MCF-7 Breast | 137 / 8712 (1.6%) | 4708 / 87120 (5.4%) | −70.5 | −68.5 | 0.29 |
| ESR1 SRX2943589 | MCF-7 Breast | 100 / 8712 (1.1%) | 4055 / 87120 (4.7%) | −70.5 | −68.5 | 0.25 |
| FOXA1 SRX5323845 | MCF-7 Breast | 67 / 8712 (0.8%) | 3424 / 87120 (3.9%) | −70.4 | −68.5 | 0.20 |
| JUNB SRX10119383 | MCF 10A Breast | 135 / 8712 (1.5%) | 4672 / 87120 (5.4%) | −70.4 | −68.5 | 0.29 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 229 / 8712 (2.6%) | 6193 / 87120 (7.1%) | −70.4 | −68.4 | 0.37 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 129 / 8712 (1.5%) | 4569 / 87120 (5.2%) | −70.4 | −68.4 | 0.28 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 199 / 8712 (2.3%) | 5721 / 87120 (6.6%) | −70.3 | −68.4 | 0.35 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 163 / 8712 (1.9%) | 5142 / 87120 (5.9%) | −70.3 | −68.4 | 0.32 |
| CEBPB SRX7807103 | Adipocytes Adipocyte | 185 / 8712 (2.1%) | 5497 / 87120 (6.3%) | −70.3 | −68.3 | 0.34 |
| AR SRX15946405 | MDA-MB-453 Breast | 122 / 8712 (1.4%) | 4442 / 87120 (5.1%) | −70.2 | −68.3 | 0.27 |
| FOXA1 SRX15430999 | T-47D Breast | 217 / 8712 (2.5%) | 6001 / 87120 (6.9%) | −70.2 | −68.2 | 0.36 |
| JUND SRX699738 | HCASMC Cardiovascular | 288 / 8712 (3.3%) | 7075 / 87120 (8.1%) | −70.2 | −68.2 | 0.41 |
| MEIS1 SRX10269610 | MOLM-13 Blood | 592 / 8712 (6.8%) | 11260 / 87120 (12.9%) | −69.9 | −68.0 | 0.53 |
| FOS SRX150664 | HUVEC Cardiovascular | 275 / 8712 (3.2%) | 6872 / 87120 (7.9%) | −69.9 | −68.0 | 0.40 |
| JUN SRX883584 | MDA-MB-231 Breast | 322 / 8712 (3.7%) | 7563 / 87120 (8.7%) | −69.8 | −67.9 | 0.43 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 199 / 8712 (2.3%) | 5706 / 87120 (6.5%) | −69.8 | −67.8 | 0.35 |
| AR SRX11149848 | MDA-MB-453 Breast | 123 / 8712 (1.4%) | 4443 / 87120 (5.1%) | −69.8 | −67.8 | 0.28 |
| FOXA1 SRX1161203 | T-47D Breast | 142 / 8712 (1.6%) | 4772 / 87120 (5.5%) | −69.7 | −67.8 | 0.30 |
| CEBPB SRX7807101 | Unclassified Unclassified | 148 / 8712 (1.7%) | 4871 / 87120 (5.6%) | −69.7 | −67.8 | 0.30 |
| JUNB SRX8488089 | SUM 229PE Breast | 211 / 8712 (2.4%) | 5887 / 87120 (6.8%) | −69.7 | −67.7 | 0.36 |
| CEBPA SRX097095 | U-937 Blood | 152 / 8712 (1.7%) | 4934 / 87120 (5.7%) | −69.6 | −67.7 | 0.31 |
| FOXA1 SRX2017929 | LNCAP Prostate | 263 / 8712 (3.0%) | 6683 / 87120 (7.7%) | −69.6 | −67.6 | 0.39 |
| ESR1 SRX4367192 | MCF-7 Breast | 416 / 8712 (4.8%) | 8873 / 87120 (10.2%) | −69.5 | −67.6 | 0.47 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 358 / 8712 (4.1%) | 8059 / 87120 (9.3%) | −69.4 | −67.5 | 0.44 |
| RELA SRX7054671 | HAEC Cardiovascular | 296 / 8712 (3.4%) | 7161 / 87120 (8.2%) | −69.3 | −67.4 | 0.41 |
| NR2F2 SRX190293 | MCF-7 Breast | 220 / 8712 (2.5%) | 6015 / 87120 (6.9%) | −69.3 | −67.3 | 0.37 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 162 / 8712 (1.9%) | 5089 / 87120 (5.8%) | −69.2 | −67.3 | 0.32 |
| ATF1 SRX11470442 | Mesenchymal stem cells Others | 269 / 8712 (3.1%) | 6756 / 87120 (7.8%) | −69.2 | −67.2 | 0.40 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 127 / 8712 (1.5%) | 4497 / 87120 (5.2%) | −69.1 | −67.2 | 0.28 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 602 / 8712 (6.9%) | 11351 / 87120 (13.0%) | −69.1 | −67.2 | 0.53 |
| GATA2 SRX150427 | HUVEC Cardiovascular | 111 / 8712 (1.3%) | 4209 / 87120 (4.8%) | −69.1 | −67.1 | 0.26 |
| GATAD2A SRX2636506 | Hep G2 Liver | 267 / 8712 (3.1%) | 6721 / 87120 (7.7%) | −69.0 | −67.1 | 0.40 |
| FOXA1 SRX5203307 | MCF-7 Breast | 54 / 8712 (0.6%) | 3120 / 87120 (3.6%) | −69.0 | −67.1 | 0.17 |
| FOSL2 SRX190204 | A549 Lung | 205 / 8712 (2.4%) | 5772 / 87120 (6.6%) | −69.0 | −67.1 | 0.36 |
| FOXA1 SRX9550928 | Prostate cancer Prostate | 251 / 8712 (2.9%) | 6476 / 87120 (7.4%) | −68.9 | −67.0 | 0.39 |
| RUNX1 SRX10119135 | MV-4-11 Blood | 222 / 8712 (2.5%) | 6030 / 87120 (6.9%) | −68.9 | −67.0 | 0.37 |
| CEBPB SRX2194247 | SUM 159PT Breast | 168 / 8712 (1.9%) | 5173 / 87120 (5.9%) | −68.9 | −66.9 | 0.32 |
| FOXA1 SRX1961158 | T-47D Breast | 196 / 8712 (2.2%) | 5626 / 87120 (6.5%) | −68.9 | −66.9 | 0.35 |
| CEBPB SRX1027439 | Mesenchymal stem cells Others | 158 / 8712 (1.8%) | 5006 / 87120 (5.7%) | −68.8 | −66.9 | 0.32 |
| ESR1 SRX20282946 | MCF-7 Breast | 123 / 8712 (1.4%) | 4411 / 87120 (5.1%) | −68.8 | −66.8 | 0.28 |
| ARID1A SRX5089391 | MCF-7 Breast | 113 / 8712 (1.3%) | 4235 / 87120 (4.9%) | −68.6 | −66.7 | 0.27 |
| SPI1 SRX2770857 | Macrophages Blood | 333 / 8712 (3.8%) | 7668 / 87120 (8.8%) | −68.6 | −66.7 | 0.43 |
| FOXA1 SRX1447316 | MCF-7 Breast | 81 / 8712 (0.9%) | 3641 / 87120 (4.2%) | −68.5 | −66.6 | 0.22 |
| MethylCap SRX014766 | NB-4 Blood | 778 / 8712 (8.9%) | 3755 / 87120 (4.3%) | −68.4 | −66.5 | 2.07 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 536 / 8712 (6.2%) | 10451 / 87120 (12.0%) | −68.4 | −66.5 | 0.51 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 192 / 8712 (2.2%) | 5544 / 87120 (6.4%) | −68.3 | −66.4 | 0.35 |
| Epitope tags SRX2255894 | 293 Kidney | 675 / 8712 (7.7%) | 3047 / 87120 (3.5%) | −68.3 | −66.4 | 2.22 |
| TET2 SRX2014505 | Jurkat Blood | 1303 / 8712 (15.0%) | 7685 / 87120 (8.8%) | −68.1 | −66.2 | 1.70 |
| RORC SRX5359052 | HCC70 Breast | 648 / 8712 (7.4%) | 2874 / 87120 (3.3%) | −68.1 | −66.2 | 2.25 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 100 / 8712 (1.1%) | 3985 / 87120 (4.6%) | −68.1 | −66.2 | 0.25 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 196 / 8712 (2.2%) | 5598 / 87120 (6.4%) | −68.1 | −66.2 | 0.35 |
| RELA SRX7054663 | HAEC Cardiovascular | 182 / 8712 (2.1%) | 5373 / 87120 (6.2%) | −68.0 | −66.1 | 0.34 |
| RUNX1 SRX2014504 | Jurkat Blood | 1185 / 8712 (13.6%) | 6768 / 87120 (7.8%) | −68.0 | −66.1 | 1.75 |
| KAT7 SRX101303 | RKO Digestive tract | 619 / 8712 (7.1%) | 2683 / 87120 (3.1%) | −68.0 | −66.1 | 2.31 |
| FOXA1 SRX5323829 | T-47D Breast | 110 / 8712 (1.3%) | 4159 / 87120 (4.8%) | −67.9 | −66.0 | 0.26 |
| CEBPB SRX4394540 | JB6 Blood | 208 / 8712 (2.4%) | 5781 / 87120 (6.6%) | −67.9 | −66.0 | 0.36 |
| FOXA2 SRX10475773 | Hep G2 Liver | 252 / 8712 (2.9%) | 6453 / 87120 (7.4%) | −67.9 | −66.0 | 0.39 |
| ESR1 SRX2881000 | MCF-7 Breast | 186 / 8712 (2.1%) | 5428 / 87120 (6.2%) | −67.9 | −66.0 | 0.34 |
| AR SRX1067068 | LHSAR Prostate | 246 / 8712 (2.8%) | 6358 / 87120 (7.3%) | −67.8 | −65.9 | 0.39 |
| SOX13 SRX2636248 | Hep G2 Liver | 286 / 8712 (3.3%) | 6949 / 87120 (8.0%) | −67.6 | −65.7 | 0.41 |
| TEAD3 SRX2636153 | Hep G2 Liver | 496 / 8712 (5.7%) | 9885 / 87120 (11.3%) | −67.6 | −65.7 | 0.50 |
| STAT3 SRX4192888 | MCF 10A Breast | 99 / 8712 (1.1%) | 3947 / 87120 (4.5%) | −67.6 | −65.7 | 0.25 |
| DLX5 SRX17306262 | Trophoblast stem cells Placenta | 252 / 8712 (2.9%) | 6434 / 87120 (7.4%) | −67.4 | −65.5 | 0.39 |
| Epitope tags SRX2867680 | 293 Kidney | 1011 / 8712 (11.6%) | 5468 / 87120 (6.3%) | −67.3 | −65.4 | 1.85 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 365 / 8712 (4.2%) | 1151 / 87120 (1.3%) | −67.2 | −65.4 | 3.17 |
| SPI1 SRX5574392 | THP-1 Blood | 387 / 8712 (4.4%) | 8378 / 87120 (9.6%) | −67.2 | −65.3 | 0.46 |
| JUN SRX6582165 | BJ-5ta Epidermis | 399 / 8712 (4.6%) | 8540 / 87120 (9.8%) | −67.1 | −65.2 | 0.47 |
| FOXA1 SRX1787654 | MCF-7 Breast | 74 / 8712 (0.8%) | 3463 / 87120 (4.0%) | −67.1 | −65.2 | 0.21 |
| Epitope tags SRX5577144 | LNCAP Prostate | 189 / 8712 (2.2%) | 5447 / 87120 (6.3%) | −67.0 | −65.1 | 0.35 |
| Epitope tags SRX15939724 | RD Muscle | 183 / 8712 (2.1%) | 5349 / 87120 (6.1%) | −66.9 | −65.1 | 0.34 |
| FLI1 SRX9738674 | A-673 Bone | 207 / 8712 (2.4%) | 5724 / 87120 (6.6%) | −66.9 | −65.0 | 0.36 |
| GATA3 SRX100559 | T-47D Breast | 225 / 8712 (2.6%) | 6004 / 87120 (6.9%) | −66.8 | −64.9 | 0.37 |
| EP300 SRX1012644 | MCF-7 Breast | 93 / 8712 (1.1%) | 3815 / 87120 (4.4%) | −66.8 | −64.9 | 0.24 |
| RELA SRX7054666 | HAEC Cardiovascular | 318 / 8712 (3.7%) | 7383 / 87120 (8.5%) | −66.8 | −64.9 | 0.43 |
| CEBPB SRX4394545 | SU-DHL-1 Bone | 210 / 8712 (2.4%) | 5766 / 87120 (6.6%) | −66.8 | −64.9 | 0.36 |
| CEBPB SRX3584202 | Epididymis Gonad | 194 / 8712 (2.2%) | 5516 / 87120 (6.3%) | −66.7 | −64.9 | 0.35 |
| FOXA1 SRX497612 | VCaP Prostate | 196 / 8712 (2.2%) | 5547 / 87120 (6.4%) | −66.7 | −64.9 | 0.35 |
| HMG20A SRX2630163 | Hep G2 Liver | 119 / 8712 (1.4%) | 4274 / 87120 (4.9%) | −66.6 | −64.8 | 0.28 |
| FOXA1 SRX142908 | LNCAP Prostate | 104 / 8712 (1.2%) | 4007 / 87120 (4.6%) | −66.5 | −64.7 | 0.26 |
| EP300 SRX22550927 | CDS1 Bone | 312 / 8712 (3.6%) | 7286 / 87120 (8.4%) | −66.5 | −64.6 | 0.43 |
| FOXA1 SRX1033292 | LNCAP Prostate | 104 / 8712 (1.2%) | 4004 / 87120 (4.6%) | −66.4 | −64.5 | 0.26 |
| NR3C1 SRX17639412 | A549 Lung | 237 / 8712 (2.7%) | 6165 / 87120 (7.1%) | −66.3 | −64.4 | 0.38 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 935 / 8712 (10.7%) | 4935 / 87120 (5.7%) | −66.3 | −64.4 | 1.89 |
| SPI1 SRX4001959 | THP-1 Blood | 232 / 8712 (2.7%) | 6089 / 87120 (7.0%) | −66.2 | −64.4 | 0.38 |
| DPF2 SRX3927297 | MOLM-13 Blood | 250 / 8712 (2.9%) | 6360 / 87120 (7.3%) | −66.2 | −64.3 | 0.39 |
| FOXA1 SRX9604646 | LNCAP Prostate | 284 / 8712 (3.3%) | 6864 / 87120 (7.9%) | −66.2 | −64.3 | 0.41 |
| FOXA1 SRX1885181 | LNCAP Prostate | 182 / 8712 (2.1%) | 5307 / 87120 (6.1%) | −66.1 | −64.3 | 0.34 |
| ESR1 SRX4451213 | MCF-7 Breast | 213 / 8712 (2.4%) | 5792 / 87120 (6.6%) | −66.1 | −64.2 | 0.37 |
| RUNX1 SRX10119136 | MV-4-11 Blood | 192 / 8712 (2.2%) | 5462 / 87120 (6.3%) | −66.1 | −64.2 | 0.35 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 247 / 8712 (2.8%) | 6308 / 87120 (7.2%) | −66.0 | −64.2 | 0.39 |
| CDK8 SRX1287844 | MOLM-14 Blood | 467 / 8712 (5.4%) | 9421 / 87120 (10.8%) | −66.0 | −64.1 | 0.50 |
| ESR1 SRX10365533 | MCF-7 Breast | 97 / 8712 (1.1%) | 3860 / 87120 (4.4%) | −65.9 | −64.1 | 0.25 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 157 / 8712 (1.8%) | 4892 / 87120 (5.6%) | −65.9 | −64.0 | 0.32 |
| MAU2 SRX11120892 | MCF-7 Breast | 82 / 8712 (0.9%) | 3580 / 87120 (4.1%) | −65.9 | −64.0 | 0.23 |
| FOXA1 SRX3931033 | MCF-7 Breast | 131 / 8712 (1.5%) | 4458 / 87120 (5.1%) | −65.9 | −64.0 | 0.29 |
| RELA SRX7054661 | HAEC Cardiovascular | 348 / 8712 (4.0%) | 7770 / 87120 (8.9%) | −65.8 | −63.9 | 0.45 |
| ARID1A SRX5089388 | MCF-7 Breast | 107 / 8712 (1.2%) | 4032 / 87120 (4.6%) | −65.6 | −63.8 | 0.27 |
| ERG SRX063922 | K-562 Blood | 772 / 8712 (8.9%) | 3777 / 87120 (4.3%) | −65.6 | −63.8 | 2.04 |
| EP300 SRX176883 | MCF-7 Breast | 98 / 8712 (1.1%) | 3867 / 87120 (4.4%) | −65.6 | −63.7 | 0.25 |
| FOXA1 SRX1161205 | T-47D Breast | 107 / 8712 (1.2%) | 4029 / 87120 (4.6%) | −65.5 | −63.6 | 0.27 |
| ARID1A SRX5089385 | MCF-7 Breast | 160 / 8712 (1.8%) | 4924 / 87120 (5.7%) | −65.4 | −63.6 | 0.32 |
| ESR1 SRX330067 | MCF-7 Breast | 196 / 8712 (2.2%) | 5504 / 87120 (6.3%) | −65.4 | −63.6 | 0.36 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 386 / 8712 (4.4%) | 8285 / 87120 (9.5%) | −65.3 | −63.5 | 0.47 |
| Epitope tags SRX15939725 | RD Muscle | 163 / 8712 (1.9%) | 4968 / 87120 (5.7%) | −65.3 | −63.4 | 0.33 |
| ESR1 SRX176856 | MCF-7 Breast | 68 / 8712 (0.8%) | 3293 / 87120 (3.8%) | −65.2 | −63.4 | 0.21 |
| ESR1 SRX1012633 | MCF-7 Breast | 112 / 8712 (1.3%) | 4108 / 87120 (4.7%) | −65.2 | −63.4 | 0.27 |
| ARID5B SRX10475139 | Hep G2 Liver | 233 / 8712 (2.7%) | 6065 / 87120 (7.0%) | −65.2 | −63.4 | 0.38 |
| FOXA1 SRX3923515 | MCF-7 Breast | 118 / 8712 (1.4%) | 4206 / 87120 (4.8%) | −65.1 | −63.3 | 0.28 |
| MYC SRX150570 | MCF 10A Breast | 139 / 8712 (1.6%) | 4565 / 87120 (5.2%) | −65.1 | −63.2 | 0.30 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 116 / 8712 (1.3%) | 4173 / 87120 (4.8%) | −65.0 | −63.2 | 0.28 |
| FOXA1 SRX9550932 | Prostate cancer Prostate | 257 / 8712 (2.9%) | 6416 / 87120 (7.4%) | −64.9 | −63.1 | 0.40 |
| ESR1 SRX330068 | MCF-7 Breast | 100 / 8712 (1.1%) | 3881 / 87120 (4.5%) | −64.9 | −63.0 | 0.26 |
| ESR1 SRX1012629 | MCF-7 Breast | 137 / 8712 (1.6%) | 4523 / 87120 (5.2%) | −64.9 | −63.0 | 0.30 |
| ESR1 SRX1012632 | MCF-7 Breast | 108 / 8712 (1.2%) | 4027 / 87120 (4.6%) | −64.9 | −63.0 | 0.27 |
| AR SRX1067069 | LHSAR Prostate | 259 / 8712 (3.0%) | 6444 / 87120 (7.4%) | −64.8 | −63.0 | 0.40 |
| RELA SRX7054615 | HAEC Cardiovascular | 233 / 8712 (2.7%) | 6048 / 87120 (6.9%) | −64.7 | −62.9 | 0.39 |
| EP300 SRX1012643 | MCF-7 Breast | 78 / 8712 (0.9%) | 3473 / 87120 (4.0%) | −64.7 | −62.9 | 0.22 |
| KDM1A SRX3321939 | Hep G2 Liver | 215 / 8712 (2.5%) | 5773 / 87120 (6.6%) | −64.7 | −62.8 | 0.37 |
| CEBPB SRX2194248 | SUM 159PT Breast | 158 / 8712 (1.8%) | 4865 / 87120 (5.6%) | −64.7 | −62.8 | 0.32 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 139 / 8712 (1.6%) | 4551 / 87120 (5.2%) | −64.7 | −62.8 | 0.31 |
| FOXA1 SRX219285 | LNCAP Prostate | 195 / 8712 (2.2%) | 5458 / 87120 (6.3%) | −64.6 | −62.8 | 0.36 |
| ESR1 SRX2881002 | MCF-7 Breast | 211 / 8712 (2.4%) | 5704 / 87120 (6.5%) | −64.5 | −62.7 | 0.37 |
| FOXA1 SRX3931032 | MCF-7 Breast | 123 / 8712 (1.4%) | 4272 / 87120 (4.9%) | −64.5 | −62.6 | 0.29 |
| ZEB1 SRX13298925 | MCF-7 Breast | 134 / 8712 (1.5%) | 4457 / 87120 (5.1%) | −64.4 | −62.6 | 0.30 |
| BRPF3 SRX796086 | RKO Digestive tract | 664 / 8712 (7.6%) | 3059 / 87120 (3.5%) | −64.4 | −62.5 | 2.17 |
| ESR1 SRX3110725 | MCF-7 Breast | 196 / 8712 (2.2%) | 5462 / 87120 (6.3%) | −64.4 | −62.5 | 0.36 |
| NR3C1 SRX10976921 | A549 Lung | 152 / 8712 (1.7%) | 4756 / 87120 (5.5%) | −64.4 | −62.5 | 0.32 |
| ESR1 SRX792933 | LY2 Breast | 173 / 8712 (2.0%) | 5100 / 87120 (5.9%) | −64.3 | −62.5 | 0.34 |
| DAXX SRX1021630 | PC-3 Prostate | 218 / 8712 (2.5%) | 5805 / 87120 (6.7%) | −64.3 | −62.5 | 0.38 |
| GFP SRX6949256 | HeLa Uterus | 228 / 8712 (2.6%) | 5957 / 87120 (6.8%) | −64.3 | −62.4 | 0.38 |
| Epitope tags SRX5877911 | U2OS Bone | 1027 / 8712 (11.8%) | 16401 / 87120 (18.8%) | −64.2 | −62.4 | 0.63 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 137 / 8712 (1.6%) | 4502 / 87120 (5.2%) | −64.2 | −62.3 | 0.30 |
| RUNX1 SRX10119134 | MV-4-11 Blood | 193 / 8712 (2.2%) | 5408 / 87120 (6.2%) | −64.1 | −62.3 | 0.36 |
| NR3C1 SRX19024866 | MCF-7 Breast | 77 / 8712 (0.9%) | 3432 / 87120 (3.9%) | −64.1 | −62.2 | 0.22 |
| RELA SRX7054618 | HAEC Cardiovascular | 217 / 8712 (2.5%) | 5780 / 87120 (6.6%) | −64.0 | −62.2 | 0.38 |
| FOXA1 SRX2017928 | LNCAP Prostate | 246 / 8712 (2.8%) | 6216 / 87120 (7.1%) | −64.0 | −62.2 | 0.40 |
| ESR1 SRX4451212 | MCF-7 Breast | 204 / 8712 (2.3%) | 5576 / 87120 (6.4%) | −64.0 | −62.2 | 0.37 |
Showing first 500 of 22257 rows.